Cha, Hye Ji
Shen, Jie
Kang, Jongkyun
Funding for this research was provided by:
National Institutes of Health (R01NS041783)
Article History
Received: 9 September 2021
Accepted: 14 December 2021
First Online: 7 January 2022
Competing interests
: H.J.C does not have any conflict of interest. J.S. has a financial interest in iNeuro Therapeutics and Paros Bio, formerly Apres Therapeutics. J.K. consults for iNeuro Therapeutics. J.S. and J.K.’s financial interests were reviewed and are managed by Mass General Brigham in accordance with their conflict of interest policies.